tm logo
NKIND
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 19 Jun 2024

Last Applicant/ Owned by

3530 John Hopkins Court

San Diego

CA

92121

Serial Number

97777750 filed on 02th Feb 2023

Registration Number

N/A

Correspondent Address

Alicia M. Passerin

Alicia M. Passerin LEECH TISHMAN FUSCALDO & LAMPL

PITTSBURGH, PA 15219

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NKIND

Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, and infectious diseases Medical services; medical Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immune-oncology, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, and infectious diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, and infectious diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases for scientific, clinical, medicinal, and therapeutic purposes; pharmaceutical preparations and substances for the prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; biological preparations for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases and infectious diseases in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment and prevention of immunologic dysfunction, autoimmune diseases, and infectious diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97777750

Mark Type

No Service Mark

Attorney Docket Number

No IBIO-76

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Jun 2024SOU EXTENSION 1 FILED
19th Jun 2024SOU EXTENSION 1 GRANTED
19th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Jun 2024SOU TEAS EXTENSION RECEIVED
06th Feb 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Dec 2023PUBLISHED FOR OPPOSITION
22nd Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Nov 2023APPROVED FOR PUB - PRINCIPAL REGISTER
07th Nov 2023EXAMINER'S AMENDMENT ENTERED